Section IV. Dialysis fluid purity

Nephrology Dialysis Transplantation

Volumn 17, Issue SUPPL. 7, 2002, Pages 45-62

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; HEMODIALYSIS FLUID;

CLINICAL PROTOCOL; CONTROLLED STUDY; DISINFECTION; HEMODIALYSIS; MICROBIAL CONTAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PURIFICATION; QUALITY CONTROL; REVIEW; WATER CONTAMINATION; WATER TREATMENT;

DIALYSIS SOLUTIONS; DISINFECTION; DRUG CONTAMINATION; HUMANS; RENAL DIALYSIS; WATER MICROBIOLOGY; WATER PURIFICATION;

EID: 0036036693     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (153)

1. Quality of water and dialysate in haemodialysis
2. Water quality and complications of haemodialysis
3. Epidemic hypotension in a dialysis center caused by sodium azide
4. High fluoride exposure in haemodialysis patients
5. Understanding the dangers of fluoride during dialysis
6. Increased silicon levels in dialysis patients due to high silicon content in the drinking water, inadequate water treatment procedures, and concentrate contamination: A multicentre study
7. Algae kills dialysis patients in Brazil
8. Fatal microcystin intoxication in haemodialysis unit in Caruaru, Brazil
9. Five years experience with a pure water system designed for haemodialysis
10. Quality of water used for haemodialysis: Bacteriological and chemical parameters
11. Reverse osmosis as a method of preparing dialysis water
12. The use of ion exchange to remove aluminum from water used in haemodialysis
13. The production of pharmaceutical grades of water using continuous deionization post-reverse osmosis
14. Aluminum determination in whole blood, dialysis solution, and tap water samples from Maracaibo dialysis units (Venezuela) by graphite furnace atomic absorption spectrometry
15. Correction of microcytosis following elimination of an occult source of aluminum contamination of dialysate
16. Aluminum exposure in chronic renal failure in iberoamerica at the end of the 1990s: Overview and perspectives
17. Aluminium and fluoride in the water supply and their removal for haemodialysis
18. Adequacy of dialysis: Trace elements in dialysis fluids
19. Trace elements and micropollutant anions in the dialysis and reinfusion fluid prepared on-line for haemodiafiltration
20. Trace elements in end-stage renal disease. 1. Methodological aspects and the influence of water treatment and dialysis equipment
21. Ultrapure water for semiconductor industry
22. The importance of water treatment in haemodialysis and haemofiltration
23. The proper sizing of ultrapure water delivery systems
24. Water treatment for contemporary haemodialysis
25. Reverse osmosis and distribution
26. Acute nickel intoxication by dialysis
27. Chloramine-induced haemolysis presenting as erythropoietin resistance
28. An outbreak of fatal fluoride intoxication in a long-term haemodialysis unit
29. Potential hazards of deionization systems used for water purification in haemodialysis
30. Increased serum strontium levels in dialysis patients: An epidemiological survey
31. Waterborne Pseudomonas septicemia
32. Pyrogenic reactions in patients receiving conventional, high-efficiency, or high-flux haemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin
33. An outbreak of Gram-negative bacteremia in haemodialysis patients traced to haemodialysis machine waste drain ports
34. A bacterial biofilm in a haemodialysis system. Assessment of disinfection and crossing of endotoxin
35. Evidence of bacterial biofilm in tubing from hydraulic pathway of haemodialysis system
36. Evaluation of recovery filters for use in bacterial retention testing of sterilizing-grade filters
37. Culture of dialysis fluids on nutrient-rich media for short periods at elevated temperatures underestimate microbial contamination
38. Improved bacteriological surveillance of haemodialysis fluids: A comparison between Tryptic soy agar and Reasoner's 2A media
39. Endotoxin contamination of biological reagents: Detection and removal of endotoxin with Limulus amebocyte lysate
40. A new chromogenic substrate method for assay of bacterial endotoxins using Limulus hemocyte lysate
41. The Limulus amebocyte lysate test: Perspectives and problems
42. Optimization of detection of bacterial endotoxin in plasma with the Limulus test
43. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods
44. Chlorine dioxide: A new agent for dialysis monitor disinfection in a pediatric center
45. Formaldehyde, sodium hypochlorite, and metabisulphite are equally effective as sterilants for central delivery systems
46. Standard methods for the microbiological assessment of electrolyte solution prepared on line for haemofiltration
47. Hemolysis associated with hydrogen peroxide at a pediatric dialysis center
48. Proper mechanisms for assuring disinfectant concentrations for use in haemodialysis
49. National surveillance of haemodialysis associated diseases in the United States, 1990
50. Outbreaks of infection and/or pyrogenic reactions in dialysis patients
51. Biofilms invade nephrology: Effects in haemodialysis
52. Persistence of microflora in biofilm within fluid pathways of contemporary haemodialyslis monitors (Gambro AK- 10)
53. Identification of the bacteriological contamination of a water treatment line used for haemodialysis and its disinfection
54. Defining the microbiological quality of dialysis fluid
55. 'On line' preparation of sterile pyrogen-free electrolyte solution
56. On-line haemodiafiltration: Technique and therapy
57. Microbiological purity of dialysate for on-line substitution fluid preparation
58. Depyrogenation of a parenteral solution by ultrafiltration
59. Convective treatments with on-line production of replacement fluid: A clinical experience lasting 6 years
60. Pyrogen retention by the Asahi APS-650 polysulfone dialyzer during in vitro dialysis with whole human donor blood
61. Application of membrane filtration for removal of diminutive bioburden organisms in pharmaceutical products and processes
62. The effect, of ultrafiltered dialysate on the cellular content of interteukin-1 receptor antagonist in patients on chronic haemodialysis
63. Bacterial cell size and surface charge characteristics relevant to filter validation studies
64. Effect of chemical germicides on the integrity of hemodialyzer membranes
65. Why and how to monitor bacterial contamination of dialysate?
66. Microbiologic contamination of liquid bicarbonate concentrate for haemodialysis
67. Salts as a source of metals in dialysis fluids: An assessment study by means of neutron activation analysis
68. Role of dialysate glucose in preventing gluconeogenesis during haemodialysis
69. The metabolic effects of haemodialysis with and without glucose in the dialysate
70. Bacterial contamination of the blood compartment originating from the dialysate in haemodialysers
71. Dialysate bacteriological quality and the permeability of dialyzer membranes to pyrogens
72. Association of high-flux dialysers and bacterial contamination of dialysate-induced chronic release of cytokines in haemodialysis patients
73. High-permeable membranes and hypersensitivity-like reactions: Role of dialysis fluid contamination
74. Diffusive and convective transfer of cytokine-inducing bacterial products across haemodialysis membranes
75. Transfer of cytokine-inducing bacterial products across hemodialyzer membranes in the presence of plasma or whole blood
76. Cytokine profiles during clinical high-flux dialysis: No evidence for cytokine generation by circulating monocytes
77. New polyether sulfone dialyzers attenuate passage of cytokine-inducing substances from Pseudomonas aeruginosa contaminated dialysate
78. Detection of bacteria in dialysate and its antibody in long-term haemodialysis patients
79. Dialysate biocompatibility: Evaluation and expectations
80. Interleukin-1 and interleukin-1 receptor antagonist production during haemodialysis: Which cytokine is a surrogate marker for dialysis-related complications?
81. Dialysis fluid and water: Their roles in biocompatibility
82. Biocompatibility in haemodialysis: Clinical relevance in 1995
83. Sterile and pyrogen-free bicarbonate dialysate: A necessity for haemodialysis today
84. Ultrafiltration of dialysis fluid to obtain a sterile solution during haemodialysis
85. In search of sterile, endotoxin-free dialysate
86. Bacteria- and endotoxin-free dialysis fluid for use in chronic haemodialysis
87. Should ultra-pure dialysate be mandatory?
88. Ultrapure dialysate: A desirable and achievable goal for routine haemodialysis
89. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during haemodialysis
90. Beta2-microglobulin and amyloidosis
91. The role of dialysate in the stimulation of interleukin-1 production during clinical haemodialysis
92. Haemodialysis-associated induction of cytokines
93. The effects of end otoxin-contaminated dialysate and polysulfone or cellulosic membranes on the release of TNF alpha during simulated dialysis
94. The role of plasma coating on the permeation of cytokine-inducing substances through dialyser membranes
95. Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis
96. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood
97. Monocyte cell-surface CD14 expression and soluble CD14 antigen in haemodialysis: Evidence for chronic exposure to LPS
98. Which level of cytokine production is critical in haemodialysis?
99. Ultrapure water for dialysate contributes to a lower activation state of peripheral blood mononuclear cells
100. Do cytokine-inducing substances penetrate through dialysis membranes and stimulate monocytes?
101. Effects of ultrapure and non-sterile dialysate on the inflammatory response during in vitro haemodialysis
102. Cytokine profiles during clinical high-flux dialysis: No evidence for cytokine generation by circulating monocytes
103. Filtration of dialysate using an on-line dialysate filter
104. A prospective study of pyrogenic reactions in haemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin
105. Bacteria and endotoxin removal from bicarbonate dialysis fluids for use in conventional, high-efficiency, and high-flux haemodialysis
106. Sterile versus non-sterile dialysis fluid in chronic haemodialysis treatment
107. Cytokine production in haemodiafiltration: A multicentre study
108. Chronic inflammation in haemodialysis: The role of contaminated dialysate
109. The link of biocompatibility to cytokine production
110. Using ultrapure water in haemodialysis delays carpal tunnel syndrome
111. Beta 2-microglobulin associated amyloidosis: A vanishing complication of long-term haemodialysis?
112. Beta2-microglobulin-derived amyloidosis: An update
113. Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients
114. The quality of dialysate: An integrated approach
115. Removal of limulus reactivity and cytokine-inducing capacity from bicarbonate dialysis fluids by ultrafiltration
116. Can sterile and pyrogen-free on-line substitution fluid be routinely delivered? A multicentric study on the microbiological safety of on-line haemodiafiltration
117. Dialysate contamination and back filtration may limit the use of high-flux dialysis membranes
118. Contamination of dialysis water and dialysate. A survey of 30 centers
119. Quality of haemodialysis water: A 7-year multicenter study
120. Microbiological quality of water and dialysate in all haemodialysis centres of Greece
121. Outbreak of pyrogenic reactions and gram-negative bacteremia in a haemodialysis center
122. Centralized on-line haemodiafiltration system utilizing purified dialysate as substitution fluid
123. Microbiologic purity of dialysate: Rationale and technical aspects
124. Water treatment equipement for hemodialysis Applications
125. Haemodialysis solutions, concentrated, water for diluting
126. Bacteriology of hemodialysis fluids: Are current methodologies meaningful?
127. Culture of dialysis fluids on nutrient-rich media for short periods at elevated temperatures underestimates microbial contamination
128. Endotoxin contamination of biological reagents: Detection and removal of endotoxin with Limulus amebocyte lysate
129. An invertebrate coagulation system activated by endotoxin: Evidence for enzymatic mediation
130. Further studies on the chromogenic substrate assay method for bacterial endotoxins using horseshoe crab (Tachypleus tridentatus) hemocyte lysate
131. Guideline on validation of the Limulus Amaebocyte Lysate Test as an End-product Endotoxin Test for Human and Animal Parenteral Drugs, Biological Products and Medical Devices
132. A modified Limulus amebocyte lysate test with increased sensitivity for detection of bacterial endotoxin
133. Optimization of detection of bacterial endotoxin in plasma with the Limulus test
134. Haemodialysis solutions, concentrated, water for diluting
135. Solutions for haemodialysis
136. Erythropoietin resistance due to dialysis fluid chloramine: The two-way traffic of solutes in haemodialysis
137. Chloramine, a sneaky contaminant of dialysis fluid
138. High level of recovery of fungi from water and dialysis fluid, in haemodialysis units
139. Bacterial contamination of haemodialysis center water and dialysis fluid: Are current assays adequate?
140. Comparison of microbiologic assay methods for a haemodialysis fluids
141. Effects of incubation time and temperature on microbiologic sampling procedures for haemodialysis fluids
142. Bacteriology of haemodialysis fluids: Are current methodologies meaningful?
143. Microbiological and endotoxin assays of haemodialysis fluids
144. New indicators to evaluate bacteriological quality of the dialysis fluid and the associated inflammatory response in ESRD patients
145. Assessment of the quality of dialysis fluid
146. Aluminium toxicity in chronic renal insufficiency
147. Biological monitoring of aluminium in renal patients
148. Cytokine production and nutritional status in haemodialysis patients
149. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome)
150. Inflammatory and atherosclerotic interactions in the depleted uremic patient
151. Plasma C-reactive protein in haemodialysis
152. C-reactive protein as a marker of chronic inflammation in uremic patients
153. Plasma C-reactive protein is linked to backfiltration associated interleukin-6 production